Maccura Biotechnology Co Ltd (300463) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million ≈ $21.78 Million USD) by net assets (CN¥6.38 Billion ≈ $933.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Maccura Biotechnology Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Maccura Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore Maccura Biotechnology Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shanghai Haohai Biological Tech Co SHG:688366	0.019x
Synsam AB ST:SYNSAM	0.144x
UniTTEC Co Ltd SHE:000925	0.017x
Lincoln Educational Services NASDAQ:LINC	0.218x
Carlyle Secured Lending Inc NASDAQ:CGBD	0.027x
Sichuan Chuanhuan Technology Co Ltd SHE:300547	-0.006x
RHOEN-KLINIK.UNSP.ADR 1/2 F:RHKU	N/A
Sanjiang Shopping Club Co Ltd SHG:601116	0.037x

Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2025. View latest Maccura Biotechnology Co Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.31 Billion ≈ $922.72 Million	CN¥602.33 Million ≈ $88.14 Million	0.096x	-3.19%
2024-12-31	CN¥6.42 Billion ≈ $939.98 Million	CN¥633.80 Million ≈ $92.74 Million	0.099x	-28.48%
2023-12-31	CN¥6.61 Billion ≈ $967.46 Million	CN¥912.09 Million ≈ $133.47 Million	0.138x	+6.83%
2022-12-31	CN¥6.53 Billion ≈ $955.50 Million	CN¥843.22 Million ≈ $123.39 Million	0.129x	-63.72%
2021-12-31	CN¥4.54 Billion ≈ $664.60 Million	CN¥1.62 Billion ≈ $236.57 Million	0.356x	+30.32%
2020-12-31	CN¥4.01 Billion ≈ $586.12 Million	CN¥1.09 Billion ≈ $160.09 Million	0.273x	+97.80%
2019-12-31	CN¥3.33 Billion ≈ $486.94 Million	CN¥459.52 Million ≈ $67.24 Million	0.138x	+104.03%
2018-12-31	CN¥2.86 Billion ≈ $419.24 Million	CN¥193.91 Million ≈ $28.37 Million	0.068x	+123.77%
2017-12-31	CN¥2.61 Billion ≈ $382.37 Million	CN¥79.03 Million ≈ $11.57 Million	0.030x	+40.04%
2016-12-31	CN¥2.28 Billion ≈ $334.12 Million	CN¥49.32 Million ≈ $7.22 Million	0.022x	+30.20%
2015-12-31	CN¥2.00 Billion ≈ $292.73 Million	CN¥33.18 Million ≈ $4.86 Million	0.017x	-88.58%
2014-12-31	CN¥792.05 Million ≈ $115.90 Million	CN¥115.09 Million ≈ $16.84 Million	0.145x	-10.73%
2013-12-31	CN¥604.48 Million ≈ $88.46 Million	CN¥98.39 Million ≈ $14.40 Million	0.163x	-35.02%
2012-12-31	CN¥442.98 Million ≈ $64.82 Million	CN¥110.96 Million ≈ $16.24 Million	0.250x	-8.71%
2011-12-31	CN¥311.77 Million ≈ $45.62 Million	CN¥85.55 Million ≈ $12.52 Million	0.274x	--

About Maccura Biotechnology Co Ltd

SHE:300463 China Diagnostics & Research

Market Cap

$803.41 Million

CN¥5.49 Billion CNY

Market Cap Rank

#9981 Global

#2624 in China

Share Price

CN¥9.08

Change (1 day)

+1.34%

52-Week Range

CN¥8.11 - CN¥14.20

All Time High

CN¥59.01